| Schedule of Investments Fair Value Measurement on Recurring Basis |
The following tables present the Company’s investments, which consist of cash equivalents and available-for-sale marketable securities, that are measured at fair value on a recurring basis as of August 31, 2026, and November 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | August 31, 2026 | | Level | | Amortized
cost | | Unrealized
gain | | Unrealized
loss | | Estimated
fair value | | Money market funds | | Level 1 | | $ | 439,429 | | | $ | — | | | $ | — | | | $ | 439,429 | | | U.S. treasury securities | | Level 1 | | 272,836 | | | 3 | | | (160) | | | 272,679 | | | Corporate debt securities | | Level 2 | | 41,599 | | | — | | | (25) | | | 41,574 | | | Corporate commercial paper | | Level 2 | | 9,767 | | | — | | | (4) | | | 9,763 | | | U.S. government agency securities | | Level 2 | | 4,000 | | | — | | | (3) | | | 3,997 | | | Long-term marketable securities: | | | | | | | | | | | | | | | | | | | | | | | Corporate debt securities | | Level 2 | | 14,853 | | | — | | | (21) | | | 14,832 | | | | | | | | | | | | | | Total | | | | $ | 782,484 | | | $ | 3 | | | $ | (213) | | | $ | 782,274 | | | Included in cash and cash equivalents | | | | $ | 439,429 | | | $ | — | | | $ | — | | | $ | 439,429 | | | Included in marketable securities, current | | | | $ | 328,202 | | | $ | 3 | | | $ | (192) | | | $ | 328,013 | | | Included in marketable securities, non-current | | | | $ | 14,853 | | | $ | — | | | $ | (21) | | | $ | 14,832 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | November 30, 2025 | | Level | | Amortized
cost | | Unrealized
gain | | Unrealized
loss | | Estimated
fair value | | Money market funds | | Level 1 | | $ | 241,364 | | | $ | — | | | $ | — | | | $ | 241,364 | | | U.S. treasury securities | | Level 1 | | 345,876 | | | 115 | | | (10) | | | 345,981 | | | | | | | | | | | | | | Total | | | | $ | 587,240 | | | $ | 115 | | | $ | (10) | | | $ | 587,345 | | | Included in cash and cash equivalents | | | | $ | 241,364 | | | $ | — | | | $ | — | | | $ | 241,364 | | | Included in marketable securities | | | | $ | 345,876 | | | $ | 115 | | | $ | (10) | | | $ | 345,981 | |
|
| Schedule of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value |
The following tables summarize the available-for-sale marketable securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of August 31, 2026, and November 30, 2025, aggregated by investment category and length of time in a continuous unrealized loss position (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Less than 12 months | | Greater than 12 months | | Total | | August 31, 2026 | | Fair Value | | Gross Unrealized Loss | | Fair Value | | Gross Unrealized Loss | | Fair Value | | Gross Unrealized Loss | | U.S. treasury securities | | $ | 255,805 | | | $ | (160) | | | $ | — | | | $ | — | | | $ | 255,805 | | | $ | (160) | | | Corporate debt securities | | 56,406 | | | (46) | | | — | | | — | | | 56,406 | | | (46) | | | Corporate commercial paper | | 9,763 | | | (4) | | | — | | | — | | | 9,763 | | | (4) | | | U.S. government agency securities | | 3,997 | | | (3) | | | — | | | — | | | 3,997 | | | (3) | | | Total | | $ | 325,971 | | | $ | (213) | | | $ | — | | | $ | — | | | $ | 325,971 | | | $ | (213) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Less than 12 months | | Greater than 12 months | | Total | | November 30, 2025 | | Fair Value | | Gross Unrealized Loss | | Fair Value | | Gross Unrealized Loss | | Fair Value | | Gross Unrealized Loss | | U.S. treasury securities | | $ | 68,755 | | | $ | (10) | | | $ | — | | | $ | — | | | $ | 68,755 | | | $ | (10) | | | | | | | | | | | | | | | | Total | | $ | 68,755 | | | $ | (10) | | | $ | — | | | $ | — | | | $ | 68,755 | | | $ | (10) | |
|